BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 30528797)

  • 1. Microscopically positive resection margin after hepatoblastoma resection: what is the impact on prognosis? A Childhood Liver Tumours Strategy Group (SIOPEL) report.
    Aronson DC; Weeda VB; Maibach R; Czauderna P; Dall'Igna P; de Ville de Goyet J; Branchereau S; Perilongo G; Brock P; Zsiros J; Semeraro M; Chardot C; Wildhaber B; Morland B; Brugières L;
    Eur J Cancer; 2019 Jan; 106():126-132. PubMed ID: 30528797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minimal adjuvant chemotherapy for children with hepatoblastoma resected at diagnosis (AHEP0731): a Children's Oncology Group, multicentre, phase 3 trial.
    Katzenstein HM; Langham MR; Malogolowkin MH; Krailo MD; Towbin AJ; McCarville MB; Finegold MJ; Ranganathan S; Dunn S; McGahren ED; Tiao GM; O'Neill AF; Qayed M; Furman WL; Xia C; Rodriguez-Galindo C; Meyers RL
    Lancet Oncol; 2019 May; 20(5):719-727. PubMed ID: 30975630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of microscopically margin-positive resection on survival in children with hepatoblastoma after hepatectomy: a retrospective cohort study.
    Ren X; Li H; Diao M; Xu H; Li L
    Int J Clin Oncol; 2020 Apr; 25(4):765-773. PubMed ID: 31701290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99].
    Häberle B; Bode U; von Schweinitz D
    Klin Padiatr; 2003; 215(3):159-65. PubMed ID: 12778356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relapses in hepatoblastoma patients: clinical characteristics and outcome--experience of the International Childhood Liver Tumour Strategy Group (SIOPEL).
    Semeraro M; Branchereau S; Maibach R; Zsiros J; Casanova M; Brock P; Domerg C; Aronson DC; Zimmermann A; Laithier V; Childs M; Roebuck D; Perilongo G; Czauderna P; Brugieres L
    Eur J Cancer; 2013 Mar; 49(4):915-22. PubMed ID: 23146961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical Resection for Hepatoblastoma-Updated Survival Outcomes.
    Sunil BJ; Palaniappan R; Venkitaraman B; Ranganathan R
    J Gastrointest Cancer; 2018 Dec; 49(4):493-496. PubMed ID: 28963691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of childhood high-risk hepatoblastoma with dose-intensive multiagent chemotherapy and surgery: final results of the SIOPEL-3HR study.
    Zsíros J; Maibach R; Shafford E; Brugieres L; Brock P; Czauderna P; Roebuck D; Childs M; Zimmermann A; Laithier V; Otte JB; de Camargo B; MacKinlay G; Scopinaro M; Aronson D; Plaschkes J; Perilongo G
    J Clin Oncol; 2010 May; 28(15):2584-90. PubMed ID: 20406943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical view of the treatment of patients with hepatoblastoma: results from the first prospective trial of the International Society of Pediatric Oncology Liver Tumor Study Group.
    Schnater JM; Aronson DC; Plaschkes J; Perilongo G; Brown J; Otte JB; Brugieres L; Czauderna P; MacKinlay G; Vos A
    Cancer; 2002 Feb; 94(4):1111-20. PubMed ID: 11920482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-dense cisplatin-based chemotherapy and surgery for children with high-risk hepatoblastoma (SIOPEL-4): a prospective, single-arm, feasibility study.
    Zsiros J; Brugieres L; Brock P; Roebuck D; Maibach R; Zimmermann A; Childs M; Pariente D; Laithier V; Otte JB; Branchereau S; Aronson D; Rangaswami A; Ronghe M; Casanova M; Sullivan M; Morland B; Czauderna P; Perilongo G;
    Lancet Oncol; 2013 Aug; 14(9):834-42. PubMed ID: 23831416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Surgical therapy of hepatoblastoma in childhood].
    von Schweinitz D; Hecker H; Bürger D; Mildenberger H
    Langenbecks Arch Chir; 1995; 380(6):315-20. PubMed ID: 8558999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment outcome and pattern of failure in hepatoblastoma treated with a consensus protocol in Hong Kong.
    Liu APY; Ip JJK; Leung AWK; Luk CW; Li CH; Ho KKH; Lo R; Chan EKW; Chan ACY; Chung PHY; Chiang AKS
    Pediatr Blood Cancer; 2019 Jan; 66(1):e27482. PubMed ID: 30270490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of postoperative complications on overall survival of patients with hepatoblastoma.
    Becker K; Furch C; Schmid I; von Schweinitz D; Häberle B
    Pediatr Blood Cancer; 2015 Jan; 62(1):24-8. PubMed ID: 25251521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival after liver transplantation for hepatoblastoma: a 2-center experience.
    Browne M; Sher D; Grant D; Deluca E; Alonso E; Whitington PF; Superina RA
    J Pediatr Surg; 2008 Nov; 43(11):1973-81. PubMed ID: 18970927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of children with hepatoblastoma who underwent liver resection at a tertiary hospital in China: a retrospective analysis.
    Li J; Li H; Wu H; Niu H; Li H; Pan J; Yang J; Tan T; Hu C; Xu T; Zhang X; Zheng M; Li K; Zou Y; Yang T
    BMC Pediatr; 2020 May; 20(1):200. PubMed ID: 32386507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment outcomes for hepatoblastoma: an institution's experience over two decades.
    Ang JP; Heath JA; Donath S; Khurana S; Auldist A
    Pediatr Surg Int; 2007 Feb; 23(2):103-9. PubMed ID: 17119981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical treatment strategy for advanced hepatoblastoma: Resection versus transplantation.
    Uchida H; Sakamoto S; Sasaki K; Takeda M; Hirata Y; Fukuda A; Hishiki T; Irie R; Nakazawa A; Miyazaki O; Nosaka S; Kasahara M
    Pediatr Blood Cancer; 2018 Dec; 65(12):e27383. PubMed ID: 30084209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multidisciplinary management of hepatoblastoma in children: Experience from a developing country.
    Shanmugam N; Scott JX; Kumar V; Vij M; Ramachandran P; Narasimhan G; Reddy MS; Kota V; Munirathnam D; Kelgeri C; Sundaram K; Rela M
    Pediatr Blood Cancer; 2017 Mar; 64(3):. PubMed ID: 27781375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mortality and morbidity in primarily resected hepatoblastomas in Japan: Experience of the JPLT (Japanese Study Group for Pediatric Liver Tumor) trials.
    Hiyama E; Hishiki T; Watanabe K; Ida K; Yano M; Oue T; Iehara T; Hoshino K; Koh K; Tanaka Y; Kurihara S; Ueda Y; Onitake Y
    J Pediatr Surg; 2015 Dec; 50(12):2098-101. PubMed ID: 26388131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role Of Surgical Treatment In The Multidisciplinary Therapy For Hepatoblastoma.
    Yada K; Ishibashi H; Mori H; Sato H; Shimada M
    Hepatogastroenterology; 2014 May; 61(131):553-6. PubMed ID: 26176034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatoblastoma in children aged less than six months at diagnosis: A report from the SIOPEL group.
    Dall'Igna P; Brugieres L; Christin AS; Maibach R; Casanova M; Alaggio R; de Goyet JV; Zsiros J; Morland B; Czauderna P; Childs M; Aronson DC; Branchereau S; Brock P; Perilongo G
    Pediatr Blood Cancer; 2018 Jan; 65(1):. PubMed ID: 28921839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.